Dawn Parsell Otto, Senior VP, Clinical Development at Tricida, Inc. (TCDA), sold 6,586 shares at $36.74 ($242K) on 2020-02-03, disclosed to the SEC on 2020-02-05.
Open-market sale of $242k TCDA by Senior VP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.58 | 258 | $9K | 3.8% |
| 2 | $35.58 | 210 | $7K | 3.1% |
| 3 | $36.74 | 2,336 | $86K | 35.4% |
| 4 | $36.74 | 2,336 | $86K | 35.4% |
| 5 | $37.31 | 523 | $20K | 8.0% |
| 6 | $37.51 | 400 |
| $15K |
| 6.2% |
| 7 | $37.62 | 523 | $20K | 8.1% |
| Total | $36.82 avg | 6,586 | $242K | 100% |
| Filing → |
| TCDA | SELL | 2020-04-30 | $172K | — | Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-01-06 | $227K | — | Filing → |